on 11 Dec 2018
Last Applicant/ Owned by
3200 Walnut Street
Boulder
CO
80301
Serial Number
87756187 filed on 16th Jan 2018
Registration Number
5625743 registered on 11th Dec 2018
Filing Basis
1. intent to use
2. use application currently
Disclaimer
"CAPSULES" AND "ENCORAFENIB"
"CAPSULES" AND "ENCORAFENIB" Color is not claimed as a feature of the mark. [ Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting oRead More
[ Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use;] Pharmaceutical products for the [ prevention and ] treatment of cancer [ and tumors; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma ]
02th Jul 2018
02th Jul 2018
No 87756187
No Service/Collective Mark
No T 428593
No
No
No
No
No
No
No
No
26.19.01 -
Spheres
The mark consists of three sphere designs diagonally above the word "BRAFTOVI" over the words encorafenib capsules, wherein the term encorafenib is in parentheses.
| Status Date | Action Taken |
|---|---|
| 02th Jan 2024 | TEAS SECTION 8 & 15 RECEIVED |
| 11th Dec 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 16th Nov 2020 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 16th Nov 2020 | AMENDMENT UNDER SECTION 7 - PROCESSED |
| 16th Jul 2020 | TEAS SECTION 7 REQUEST RECEIVED |
| 04th Jun 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 04th Jun 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 04th Jun 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 04th Jun 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 04th Jun 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
